The opioid overdose epidemic is typically described as having occurred in 3 waves, with
morbidity and mortality accruing over time principally from prescription opioids (1999–2010) …

Background Currently, there are no accepted FDA-approved pharmacotherapies for cocaine
use disorder, though numerous medications have been tested in clinical trials. We …

In 2017, among 70,237 drug overdose deaths, 47,600 (67.8%) involved opioids, with
increases across age groups, racial/ethnic groups, county urbanization levels, and in …

From 1999 to 2015, the drug overdose epidemic resulted in approximately 568,699 deaths.
In 2015, 52,404 drug overdose deaths occurred; 63.1%(33,091) involved an opioid. From …

From 2016 to 2017, death rates involving cocaine and psychostimulants increased across
age groups, racial/ethnic groups, county urbanization levels, and multiple states. Death rates …

INTRODUCTION The epidemic of substance use disorders and drug overdose deaths is a
growing public health crisis in the United States. Every day, 174 people die from drug …

Objective—This report identifies the specific drugs involved most frequently in drug
overdose deaths in the United States from 2011 through 2016. Methods—Record-level data …

Background Drug overdose deaths involving stimulants, including cocaine and
psychostimulants with abuse potential (eg, methamphetamine), have been increasing, partly …

Aims To examine trends and recent changes in non‐fatal and fatal stimulant overdose rates
with and without opioids to improve the descriptive characterization of the US overdose …

Background and aims While prescribed and illicit opioid use are primary drivers of the
national surges in overdose deaths, opioid overdose deaths in which stimulants are also …